Stratification of CD Subjects by NOD2 and ATG16L1 Variants
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Second Hospital of Hebei Medical University
Other organizations : University of California, Los Angeles
Variable analysis
- ATG16L1 CD-associated T300A variant status
- Homozygous non-risk or homozygous risk for the 3 common CD-associated NOD2 variants (tagged by rs2066842-GG, rs2066844-GG, rs2066845-CC. rs5743293-DD)
- Not explicitly mentioned
- All human subjects were homozygous non-risk for the 3 common CD-associated NOD2 variants (tagged by rs2066842-GG, rs2066844-GG, rs2066845-CC. rs5743293-DD)
- All study subjects had not used antibiotics for at least 6 months
- Stool, blood samples, and genetic data were obtained from Material and Information Resources for Inflammatory And Digestive Diseases (MIRIAD) IBD Biobank
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!